학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 9건 | 목록 1~10
Academic Journal
Triller G; Laboratory of Lymphocyte Biology, The Rockefeller University, New York, NY 10065, USA.; Garyfallos DA; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK.; Papavasiliou FN; Division of Immune Diversity, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.; Sklaviadis T; Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.; Stavropoulos P; Laboratory of Lymphocyte Biology, The Rockefeller University, New York, NY 10065, USA.; Xanthopoulos K; Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.; Institute of Applied Biosciences, Centre for Research and Technology Hellas, 57001 Thermi, Greece.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Gozdecka M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Meduri E; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Mazan M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Dudek M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Knights AJ; Genomics of Gene Regulation, Wellcome Trust Sanger Institute, Hinxton, UK.; Pardo M; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Yu L; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Choudhary JS; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Metzakopian E; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.; Iyer V; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Yun H; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Park N; Sequencing Research Group, Wellcome Trust Sanger Institute, Cambridge, UK.; Varela I; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.; Bautista R; New Pipeline Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Collord G; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Dovey O; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Kondo S; Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; Cooper J; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Göttgens B; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Bullinger L; Department of Internal Medicine III, Ulm University Medical Centre, Ulm, Germany.; Medical Department, Division of Hematology, Oncology and Tumour Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Northcott PA; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.; Adams D; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk.; Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. bjph2@cam.ac.uk.
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Orellana EA; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Liu Q; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; Yankova E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Milner Therapeutics Institute, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK; Storm Therapeutics Ltd., Moneta Building (B280), Babraham Research Campus, Cambridge CB22 3AT, UK.; Pirouz M; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.; De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; Zhang W; Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Lim J; Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.; Aspris D; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Karaiskakio Foundation, Nicandrou Papamina Avenue, 2032 Nicosia, Cyprus.; Sendinc E; Division of Newborn Medicine and Epigenetics Program, Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA.; Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK.; Gu M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.; Ali R; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.; Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Mikutis S; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.; Bernardes GJL; Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.; Fischer ES; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Bradley A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK.; Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Karaiskakio Foundation, Nicandrou Papamina Avenue, 2032 Nicosia, Cyprus; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK.; Slack FJ; Department of Pathology, Cancer Center, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Harvard Initiative for RNA Medicine, Boston, MA 02115, USA.; Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK; Milner Therapeutics Institute, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Puddicombe Way, Cambridge CB2 0AW, UK. Electronic address: kt404@cam.ac.uk.; Gregory RI; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Harvard Initiative for RNA Medicine, Boston, MA 02115, USA. Electronic address: rgregory@enders.tch.harvard.edu.
Publisher: Cell Press Country of Publication: United States NLM ID: 9802571 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4164 (Electronic) Linking ISSN: 10972765 NLM ISO Abbreviation: Mol Cell Subsets: MEDLINE
Academic Journal
Kotsaris G; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Present Address: Institute for Chemistry and Biochemistry, Freie Universität Berlin, Thielallee 63, 14195 Berlin, Germany.; Kerselidou D; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Present Address: Université de Liège, Place du 20-Août, 7 B, 4000 Liège, Belgium.; Koutsoubaris D; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Constantinou E; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Malamas G; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Garyfallos DA; Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.; Present Address: Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire, CB10 1SA UK.; Ηatzivassiliou EG; Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Macedonia Greece.
Publisher: Aristotle University of Thessaloniki Country of Publication: Greece NLM ID: 101248115 Publication Model: eCollection Cited Medium: Print ISSN: 1790-045X (Print) Linking ISSN: 1790045X NLM ISO Abbreviation: J Biol Res (Thessalon) Subsets: PubMed not MEDLINE
Academic Journal
Yang J; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Rajan SS; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; UK Dementia Research Institute, Department of Clinical Neuroscience, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0AH, UK.; Friedrich MJ; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Lan G; Cancer Research UK, Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Zou X; Cancer Research UK, Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK.; Ponstingl H; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Garyfallos DA; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Liu P; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, Stem Cell and Regenerative Medicine Consortium, University of Hong Kong, Hong Kong, China.; Bradley A; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Metzakopian E; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK; UK Dementia Research Institute, Department of Clinical Neuroscience, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0AH, UK. Electronic address: em698@medschl.cam.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 101611300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-6711 (Electronic) Linking ISSN: 22136711 NLM ISO Abbreviation: Stem Cell Reports Subsets: MEDLINE
Academic Journal
Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. kt404@cam.ac.uk.; Gurdon Institute and Department of Pathology, Tennis Court Road, Cambridge, CB2 1QN, UK. kt404@cam.ac.uk.; De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Aspris D; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Karaiskakio Foundation, Nicosia, Cyprus.; Barbieri I; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrookes Hospital, CB2 0QQ, Cambridge, UK.; Vijayabaskar MS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Liu WH; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 81377, Munich, Germany.; Gozdecka M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0XY, UK.; Metzakopian E; UK Dementia Research Institute, University of Cambridge, Hills Rd, Cambridge, CB2 0AH, UK.; Toop HD; School of Chemistry, University of New South Wales, Sydney, Australia.; Exonate Ltd, Milton Science Park, Cambridge, UK.; Dudek M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Robson SC; School of Pharmacy and Biomedical Science, University of Portsmouth, White Swan Road, Portsmouth, PO1 2DT, UK.; Hermida-Prado F; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Yang YH; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Babaei-Jadidi R; School of Chemistry, University of New South Wales, Sydney, Australia.; Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Ponstingl H; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Dias JML; Cancer Molecular Diagnosis Laboratory, National Institute for Health Research, Biomedical Research Centre, University of Cambridge, Cambridge, UK.; Gallipoli P; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0XY, UK.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, CB2 0QQ, UK.; Seiler M; H3 Biomedicine Inc., Cambridge, MA, USA.; Buonamici S; H3 Biomedicine Inc., Cambridge, MA, USA.; Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 81377, Munich, Germany.; Bannister AJ; Gurdon Institute and Department of Pathology, Tennis Court Road, Cambridge, CB2 1QN, UK.; Rad R; Institute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center, Technical University of Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, & German Cancer Consortium (DKTK), Heidelberg, Germany.; Prinjha RK; Epigenetics DPU, Immunoinflammation and Oncology TA Unit, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK.; Marioni JC; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 0RE, UK.; European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK.; Stem Cell Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.; Huntly B; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0XY, UK.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, CB2 0QQ, UK.; Batson J; Exonate Ltd, Milton Science Park, Cambridge, UK.; Morris JC; School of Chemistry, University of New South Wales, Sydney, Australia.; Exonate Ltd, Milton Science Park, Cambridge, UK.; Pina C; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, UK.; Bradley A; Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), 81377, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, & German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University München, 80337, Munich, Germany.; Bates DO; Exonate Ltd, Milton Science Park, Cambridge, UK.; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, NG2 7UH, UK.; Yusa K; Stem Cell Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. ky1@sanger.ac.uk.; Kouzarides T; Gurdon Institute and Department of Pathology, Tennis Court Road, Cambridge, CB2 1QN, UK. t.kouzarides@gurdon.cam.ac.uk.; Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0XY, UK. gsv20@sanger.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, CB2 0PT, UK. gsv20@sanger.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Gozdecka M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Meduri E; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Mazan M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Dudek M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Knights AJ; Genomics of Gene Regulation, Wellcome Trust Sanger Institute, Hinxton, UK.; Pardo M; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Yu L; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Choudhary JS; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Metzakopian E; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, UK.; Iyer V; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Yun H; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Park N; Sequencing Research Group, Wellcome Trust Sanger Institute, Cambridge, UK.; Varela I; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain.; Bautista R; New Pipeline Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Collord G; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Dovey O; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Kondo S; Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; Cooper J; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Göttgens B; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK.; Bullinger L; Department of Internal Medicine III, Ulm University Medical Centre, Ulm, Germany.; Medical Department, Division of Hematology, Oncology and Tumour Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Northcott PA; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.; Adams D; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk.; Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. bjph2@cam.ac.uk.
Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Academic Journal
Zervou MI; Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion 71003, Greece.; Dimopoulou DG; 4th Department of Internal Medicine, Hippocratio Hospital, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.; Eliopoulos E; Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens 11855, Greece.; Trachana M; 1st Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.; Pratsidou-Gkertsi P; 1st Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.; Andreou A; Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens 11855, Greece.; Sidiropoulos P; Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion 71500, Greece.; Spandidos DA; Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion 54124, Greece.; Garyfallos A; 4th Department of Internal Medicine, Hippocratio Hospital, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.; Goulielmos GN; Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion 71003, Greece.
Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-3004 (Electronic) Linking ISSN: 17912997 NLM ISO Abbreviation: Mol Med Rep Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Garyfallos DA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어